| Name | 7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile |
|---|---|
| Synonyms |
7-chloro-9-oxoindeno[1,2-b]pyrazine-2,3-dicarbonitrile
HBX41108 |
| Description | HBX 41108 is an uncompetitive inhibitor of ubiquitin-specific protease 7 (USP7) with an IC50 of 424 nM. HBX 41108 inhibits USP7-mediated p53 deubiquitination to stabilize p53 and inhibits cancer cell growth. HBX 41108 induces p53-dependent apoptosis in p53 wild type and null isogenic cancer cell lines[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.66g/cm3 |
|---|---|
| Boiling Point | 604.9ºC at 760 mmHg |
| Molecular Formula | C13H3ClN4O |
| Molecular Weight | 266.64200 |
| Flash Point | 319.6ºC |
| Exact Mass | 266.00000 |
| PSA | 90.43000 |
| LogP | 2.08476 |
| Index of Refraction | 1.725 |
|
~40%
924296-39-9 |
| Literature: Hybrigenics S.A. Patent: EP1749822 A1, 2007 ; Location in patent: Page/Page column 28 ; EP 1749822 A1 |
|
~%
924296-39-9 |
| Literature: ChemMedChem, , vol. 5, # 4 p. 552 - 558 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |